Stocks
OrganiGram Holdings Financial Statements (OGI) |
||||||||||
| OrganiGram Holdingssmart-lab.ru | % | 2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.05.2023 | 14.07.2023 | 30.09.2023 | 13.02.2024 | 14.05.2024 | 14.05.2024 | ||||
| Currency | CAD | CAD | CAD | CAD | CAD | CAD | ||||
| Financial report URL | ||||||||||
| Revenue, C$ | ? | 32 785 000 | 32 785 000 | 46 040 000 | 36 455 000 | 37 628 000 | 152 908 000 | |||
| Operating Income, C$ | -219 637 000 | -219 637 000 | -39 361 000 | -15 929 000 | -24 377 000 | -299 304 000 | ||||
| EBITDA, C$ | ? | -21 653 000 | -21 653 000 | -33 939 000 | -13 029 000 | -21 247 000 | -89 868 000 | |||
| Net profit, C$ | ? | -213 451 000 | -213 451 000 | -32 991 000 | -15 750 000 | -27 075 000 | -289 267 000 | |||
| OCF, C$ | ? | -5 515 000 | -5 515 000 | -15 962 000 | 7 687 000 | -8 263 000 | -22 053 000 | |||
| CAPEX, C$ | ? | 9 144 000 | 9 144 000 | 7 335 000 | 1 526 000 | 445 000 | 18 450 000 | |||
| FCF, C$ | ? | -14 659 000 | -14 659 000 | -23 297 000 | 6 161 000 | -8 708 000 | -40 503 000 | |||
| Dividend payout, C$ | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, C$ | 23 698 000 | 23 698 000 | 26 615 000 | 22 629 000 | 23 469 000 | 96 411 000 | ||||
| Cost of production, C$ | 37 482 000 | 37 482 000 | 58 786 000 | 29 755 000 | 38 536 000 | 164 559 000 | ||||
| R&D, C$ | 3 463 000 | 3 463 000 | 4 006 999 | 4 467 000 | 2 606 000 | 14 542 999 | ||||
| Interest expenses, C$ | 64 000 | 64 000 | 133 000 | 48 000 | 65 000 | 310 000 | ||||
| Assets, C$ | 348 515 000 | 348 515 000 | 298 455 000 | 299 014 000 | 331 778 000 | 331 778 000 | ||||
| Net Assets, C$ | ? | 301 987 000 | 301 987 000 | 271 623 000 | 257 825 000 | 271 797 000 | 271 797 000 | |||
| Debt, C$ | 180 000 | 180 000 | 4 719 000 | 136 000 | 118 000 | 118 000 | ||||
| Cash, C$ | 53 036 000 | 53 036 000 | 33 864 000 | 42 330 000 | 72 606 000 | 72 606 000 | ||||
| Net debt, C$ | -52 856 000 | -52 856 000 | -29 145 000 | -42 194 000 | -72 488 000 | -72 488 000 | ||||
| Ordinary share price, rub | 1.48 | 1.48 | 1.32 | 1.31 | 2.15 | 1.10 | ||||
| Number of ordinary shares, mln | 78 822 378 | 80 492 621 | 81 161 630 | 81 161 630 | 91 161 616 | 91 161 616 | ||||
| Market cap, C$ | 116 657 119 | 119 129 079 | 107 133 352 | 106 321 735 | 195 997 474 | 100 277 778 | ||||
| EV, C$ | ? | 63 801 119 | 66 273 079 | 77 988 352 | 64 127 735 | 123 509 474 | 27 789 778 | |||
| Book value, C$ | 284 228 000 | 284 228 000 | 271 623 000 | 257 825 000 | 271 797 000 | 271 797 000 | ||||
| EPS, rub | ? | -2.71 | -2.65 | -0.41 | -0.19 | -0.30 | -3.17 | |||
| FCF/share, rub | -0.19 | -0.18 | -0.29 | 0.08 | -0.10 | -0.44 | ||||
| BV/share, rub | 3.61 | 3.53 | 3.35 | 3.18 | 2.98 | 2.98 | ||||
| EBITDA margin, % | ? | -66.0% | -66.0% | -73.7% | -35.7% | -56.5% | -58.8% | |||
| Net margin, % | ? | -651.1% | -651.1% | -71.7% | -43.2% | -72.0% | -189.2% | |||
| FCF yield, % | ? | -68.9% | -67.5% | -63.6% | -53.7% | -20.7% | -40.4% | |||
| ROE, % | ? | -73.4% | -73.4% | -91.5% | -104.6% | -106.4% | -106.4% | |||
| ROA, % | ? | -63.6% | -63.6% | -83.3% | -90.2% | -87.2% | -87.2% | |||
| P/E | ? | -0.53 | -0.54 | -0.43 | -0.39 | -0.68 | -0.35 | |||
| P/FCF | -7.96 | -1.48 | -1.57 | -1.86 | -4.84 | -2.48 | ||||
| P/S | ? | 0.72 | 0.74 | 0.66 | 0.69 | 1.28 | 0.66 | |||
| P/BV | ? | 0.41 | 0.42 | 0.39 | 0.41 | 0.72 | 0.37 | |||
| EV/EBITDA | ? | -4.12 | -4.28 | -1.58 | -0.88 | -1.37 | -0.31 | |||
| Debt/EBITDA | 3.41 | 3.41 | 0.59 | 0.58 | 0.81 | 0.81 | ||||
| R&D/CAPEX, % | 37.9% | 37.9% | 54.6% | 292.7% | 585.6% | 78.8% | ||||
| CAPEX/Revenue, % | 27.9% | 27.9% | 15.9% | 4.19% | 1.18% | 12.1% | ||||
| OrganiGram Holdings shareholders | ||||||||||
